ConductScience.org, home

Paper658097

Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agents.

Barlogie B and 1 other. Eur J Cancer (1965), 1978. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agents. Papers, record 658097. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/658097

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agents.
PubMed
Journal
Eur J Cancer (1965)
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
2.15
iCite
Revised in PubMed
2019-09-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barlogie BB
2Drewinko BB

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cell CycleMajor topic
Cells, Cultured
Depression, Chemical
Humans
Lymphoma
Time Factors

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
21033700A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.Biochemistry2010https://conductscience.org/library/papers/21033700PubMed
12201486Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro.Invest New Drugs2002https://conductscience.org/library/papers/12201486PubMed
10857993Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines.Invest New Drugs2000https://conductscience.org/library/papers/10857993PubMed
9743293Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.Br J Cancer1998https://conductscience.org/library/papers/9743293PubMed
7340985A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7340985PubMed
7031350[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].Klin Wochenschr1981https://conductscience.org/library/papers/7031350PubMed
6684118Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.J Cancer Res Clin Oncol1983https://conductscience.org/library/papers/6684118PubMed
6196896Flow-cytophotometric studies on urine sediments of patients treated with anti-cancer-drugs.Urol Res1983https://conductscience.org/library/papers/6196896PubMed
3297462The clinical pharmacology of etoposide and teniposide.Clin Pharmacokinet1987https://conductscience.org/library/papers/3297462PubMed
1624543Spectrum of cell-cycle kinetics of alkylating agent adolezesin in gynecological cancer cell lines: correlation with drug-induced cytotoxicity.J Cancer Res Clin Oncol1992https://conductscience.org/library/papers/1624543PubMed
1333370Potentiation of etoposide-induced cytotoxicity and DNA damage in CCRF-CEM cells by pretreatment with non-cytotoxic concentrations of arabinosyl cytosine.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1333370PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/658097

GET https://conductscience.org/api/papers/v1/658097/authors